Table 6 Univariate analyses of correlated factors for Bhalla scores in bronchiectasis patients
Variables | Bhalla score | ||
|---|---|---|---|
r | 95% CI | P value | |
Male sex | 0.19 | − 0.54 to 0.92 | 0.602 |
Age | 0.01 | − 0.01 to 0.04 | 0.368 |
BMI | − 0.09 | − 0.17 to − 0.01 | 0.035 |
Positive smoking statusa | 0.75 | 0.00 to 1.50 | 0.050 |
Smoking indexb | 0.08 | − 0.12 to 0.27 | 0.429 |
Duration of asthma | − 0.00 | − 0.03 to 0.02 | 0.811 |
NPs | 0.81 | 0.10 to 1.51 | 0.026 |
Prior sinus surgery | 0.02 | − 0.82 to 0.86 | 0.965 |
Allergic rhinitis | 0.06 | − 0.72 to 0.84 | 0.876 |
Atopic dermatitis | − 1.09 | − 2.88 to 0.71 | 0.232 |
Gastroesophageal reflux disease | − 0.69 | − 2.11 to 0.73 | 0.335 |
ICS dose (fluticasone equivalent) | 0.00 | − 0.00 to 0.00 | 0.468 |
Severe asthma | 0.62 | − 0.26 to 1.50 | 0.164 |
≥ 1 severe exacerbation of asthma in the last 12 months | 0.27 | − 0.46 to 1.00 | 0.469 |
≥ 1 pneumonia in the last 12 months | 0.50 | − 0.26 to 1.26 | 0.194 |
Peripheral blood eosinophil counts | 0.19 | − 0.36 to 0.74 | 0.493 |
FeNO | 0.01 | 0.00 to 0.02 | 0.044 |
Total IgE | 0.00 | 0.00 to 0.00 | 0.468 |
Atopy | − 0.30 | − 1.03 to 0.42 | 0.408 |
Postbronchodilator FEV1% predicted | − 0.02 | − 0.03 to 0.00 | 0.045 |
LM scores | 0.05 | 0.00 to 0.11 | 0.060 |